Fortress Biotech, Inc. · NASDAQ:FBIO
Jin David bought 47,605 Fortress Biotech, Inc. shares (Form 4)
Traded Nov 17 to Nov 19, 2026 · Filed Nov 19, 2026
From Nov 17 to Nov 19, 2026, Jin David (Chief Financial Officer) bought 47,605 Fortress Biotech, Inc. shares at an average US$1.84 for US$87,814, leaving 1,700,366 shares. Filed Nov 19, 2026 (Form 4).
- Bought
- 47,605 shares
- Price
- US$1.84 average (US$1.72 to US$1.91)
- Value
- US$87,814
- Holding after
- 1,700,366 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 17, 2026 | Common Stock, par value $0.001 | Buy | 15,000 | US$1.72 | 1,667,761 | Direct |
| Nov 18, 2026 | Common Stock, par value $0.001 | Buy | 25,000 | US$1.91 | 1,692,761 | Direct |
| Nov 19, 2026 | Common Stock, par value $0.001 | Buy | 7,605 | US$1.87 | 1,700,366 | Direct |
Source
Download original · View original at SEC
Related
- Fortress Biotech, Inc.
- Jin David
- Fortress Biotech, Inc. shareholders
- Form 4 · Jin David · Oct 1, 2026
- Form 4 · Jin David · Jun 24, 2026
- Form 4 · Jin David · Apr 1, 2026
- Form 4 · Rosenwald Lindsay A Md · Nov 19, 2026
- Schedule 13G/A · Millennium Management LLC · Oct 29, 2026
- Schedule 13G · Millennium Management LLC · Sep 1, 2026
- Schedule 13G/A · Highbridge Capital Management LLC · May 15, 2026
- Schedule 13D/A · Rosenwald Lindsay A Md · Mar 20, 2026